NHIF Announces 2022-2023 Board of Directors
March 22, 2022
The National Home Infusion Foundation (NHIF) is proud to announce that Mitra Gavgani, PharmD has joined its Board of Directors for the 2022-2023 term.
Menu
The National Home Infusion Foundation (NHIF) is proud to announce that Mitra Gavgani, PharmD has joined its Board of Directors for the 2022-2023 term.
NHIA submitted comments on a CMS proposed rule: Medicare and Medicaid Programs; CY 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs, which would alter the way pharmacy price concessions, including direct and indirect remuneration (DIR fees), are calculated by pharmacy benefit managers (PBMs).
The National Home Infusion Association (NHIA) is proud to announce that Erick Siegenthaler, PharmD, MHA, has joined the association’s Board of Directors for a 3-year term.
View photos from NHIA’s 2022 Annual Conference held in Nashville, Tennessee March 12-16.
More than 1,200 home infusion therapy professionals and 110 companies supplying products and services to the industry attended educational and networking events as well as a trade Expo.
The National Home Infusion Foundation (NHIF) is proud to announce that the recipient of the 2022 Outstanding Abstract Achievement Award (OAAA) is Cheyenne D. Johnson, PharmD from Option Care Health.
Danell Haines, PhD, Research Consultant; Ryan Garst, PharmD, MBA, IgCP, BCSCP, NHIA; Connie Sullivan, BSPharm, NHIA; Jennifer Charron, RN, MSN, MBA, NHIA
Pharmacist professional services are paramount to the success of the home infusion process. Using home infusion pharmacist time utilization data collected in this study, the amount of time the home infusion pharmacist spends managing and caring for the patient was determined. The categories of professional services the pharmacist provides and the time and task differences between therapy types and methods of administration was also determined.
Steven Ward, WellSky; Bill Noyes, NHIA; Connie Sullivan, BSPharm, NHIA; Danell Haines, PhD, Research Consultant
Approximately 15% of the U.S. population lives in rural areas. It is recognized that rural Americans have fewer health care opportunities when compared to metropolitan residents. This study aimed to determine the annual percentage of home infusion patients living and receiving home infusion services in rural areas.
Mary Beth Letourneau, PharmD, New England Life Care; Erica Sievert, PharmD, New England Life Care; Amy MacInnis, PharmD, New England Life Care
Patients who administer chronic parenteral diphenhydramine are at risk of developing behavioral issues that may represent misuse or abuse. The purpose of this study was to assess potential risk factors and comorbidities for medication noncompliance in the home infusion patient population prescribed parenteral diphenhydramine.
The National Home Infusion Foundation (NHIF) announces the finalists for its the Outstanding Abstract Achievement Award for 2022.
The National Home Infusion Association (NHIA) is pleased to announce the 2022 Fellow Program (FNHIA) cohort, made up of highly accomplished home and alternate site infusion professionals. The program is administered and funded by the National Home Infusion Foundation (NHIF), thanks to a generous contribution from Integrated Medical Systems, Inc. (IMS), the 2022 sponsor of the NHIA Fellow Program.
The National Home Infusion Foundation (NHIF) is proud to announce that Melissa Leone, RN, BSN is the recipient of the 2022 Lynn Giglione Women in Leadership Award.
The National Home Infusion Association (NHIA) is proud to announce that Dr. Sohail Masood, PharmD is the recipient of the 2022 Gene Graves Lifetime Achievement Award.
CMS recently issued a report which summarizes utilization trends for the Medicare Part B home infusion therapy (HIT) services benefit indicating the benefit has failed to draw sufficient participation from providers to ensure equitable access to beneficiaries across the U.S.
Free for all members, NHIA University houses our complete library of educational content for all roles and interests within home and alternate site infusion. The categorized and searchable interface provides a personalized learning dashboard tied to your NHIA member account and includes all of our continuing education (CE) credit offerings for Pharmacists, Pharmacy Technicians, RNs & RDs.
NHIA has developed product shortage recommendations to help clinicians manage patients during this time when diluents, and small and large volume parenteral solutions may not be readily available.
The groups ask regulators to assess the impact of these businesses on critical drug shortages and for states to regulate them appropriately.
The National Home Infusion Foundation (NHIF) is proud to announce that Mitra Gavgani, PharmD has joined its Board of Directors for the 2022-2023 term.
NHIA submitted comments on a CMS proposed rule: Medicare and Medicaid Programs; CY 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs, which would alter the way pharmacy price concessions, including direct and indirect remuneration (DIR fees), are calculated by pharmacy benefit managers (PBMs).
The National Home Infusion Association (NHIA) is proud to announce that Erick Siegenthaler, PharmD, MHA, has joined the association’s Board of Directors for a 3-year term.
View photos from NHIA’s 2022 Annual Conference held in Nashville, Tennessee March 12-16.
More than 1,200 home infusion therapy professionals and 110 companies supplying products and services to the industry attended educational and networking events as well as a trade Expo.
The National Home Infusion Foundation (NHIF) is proud to announce that the recipient of the 2022 Outstanding Abstract Achievement Award (OAAA) is Cheyenne D. Johnson, PharmD from Option Care Health.
Danell Haines, PhD, Research Consultant; Ryan Garst, PharmD, MBA, IgCP, BCSCP, NHIA; Connie Sullivan, BSPharm, NHIA; Jennifer Charron, RN, MSN, MBA, NHIA
Pharmacist professional services are paramount to the success of the home infusion process. Using home infusion pharmacist time utilization data collected in this study, the amount of time the home infusion pharmacist spends managing and caring for the patient was determined. The categories of professional services the pharmacist provides and the time and task differences between therapy types and methods of administration was also determined.
Steven Ward, WellSky; Bill Noyes, NHIA; Connie Sullivan, BSPharm, NHIA; Danell Haines, PhD, Research Consultant
Approximately 15% of the U.S. population lives in rural areas. It is recognized that rural Americans have fewer health care opportunities when compared to metropolitan residents. This study aimed to determine the annual percentage of home infusion patients living and receiving home infusion services in rural areas.
Mary Beth Letourneau, PharmD, New England Life Care; Erica Sievert, PharmD, New England Life Care; Amy MacInnis, PharmD, New England Life Care
Patients who administer chronic parenteral diphenhydramine are at risk of developing behavioral issues that may represent misuse or abuse. The purpose of this study was to assess potential risk factors and comorbidities for medication noncompliance in the home infusion patient population prescribed parenteral diphenhydramine.
The National Home Infusion Foundation (NHIF) announces the finalists for its the Outstanding Abstract Achievement Award for 2022.
The National Home Infusion Association (NHIA) is pleased to announce the 2022 Fellow Program (FNHIA) cohort, made up of highly accomplished home and alternate site infusion professionals. The program is administered and funded by the National Home Infusion Foundation (NHIF), thanks to a generous contribution from Integrated Medical Systems, Inc. (IMS), the 2022 sponsor of the NHIA Fellow Program.
The National Home Infusion Foundation (NHIF) is proud to announce that Melissa Leone, RN, BSN is the recipient of the 2022 Lynn Giglione Women in Leadership Award.
The National Home Infusion Association (NHIA) is proud to announce that Dr. Sohail Masood, PharmD is the recipient of the 2022 Gene Graves Lifetime Achievement Award.
CMS recently issued a report which summarizes utilization trends for the Medicare Part B home infusion therapy (HIT) services benefit indicating the benefit has failed to draw sufficient participation from providers to ensure equitable access to beneficiaries across the U.S.
Free for all members, NHIA University houses our complete library of educational content for all roles and interests within home and alternate site infusion. The categorized and searchable interface provides a personalized learning dashboard tied to your NHIA member account and includes all of our continuing education (CE) credit offerings for Pharmacists, Pharmacy Technicians, RNs & RDs.
NHIA has developed product shortage recommendations to help clinicians manage patients during this time when diluents, and small and large volume parenteral solutions may not be readily available.
The groups ask regulators to assess the impact of these businesses on critical drug shortages and for states to regulate them appropriately.